comprehensive -WSS

comprehensive

author：knowledge 2025-08-10 11:42:40 - browse：6

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Traditional Chinese medicine benefits explored in new JAMA study

hotspot

knowledge

WSS

ProMED sees offers of support, but its future remains unclear

Readout Newsletter: XBI biotech index, Akero Therapeutics

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: What happened with Sarepta's Duchenne data

Liz Cheney makes 1st public comment since Trump's election interference indictments

Eye stem cell transplant could help restore vision in injured people

focus

comprehensive

hotspot

Continuity nursing helped my family in our darkest PICU moments

Beware the threat of staffing cuts at the CDC

Virginia high school admissions case could be legal follow

The pink breast cancer awareness ribbon needs a redesign

Apple is now the first public company to be valued at $3 trillion

Diversifying clinical trials isn't enough to close racial gaps: study

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Baltimore teen accused of firing into crowd during block party mass shooting

At least 13 dead in Texas as scorching temps continue

Lung cancer is America's deadliest cancer. Yet so few get screened

focus

Eli Lilly to pay $200M for Beam’s stake in gene

Cancer drug shortages' outsize impact on ovarian cancer patients

Congress must give Medicare recipients genetic counseling access

An interview with Robert F. Kennedy Jr. on vaccines

Why Sanofi got shellacked over its spinoff

Eye stem cell transplant could help restore vision in injured people

hotspot

knowledge

leisure time

leisure time